Bristol-Myers Senior Vice President Andrew Bodnar compares the situation with Erbitux to the chemotherapy agent Taxol, which was initially approved only for ovarian cancer, a relatively uncommon tumor.
That, he says, is exactly what would be needed for the drug to be approved by the Food and Drug Administration as a disease-modifying agent, not just a treatment of symptoms.
"We did not pay an agent when Benjani joined from Auxerre, and his transfer to Manchester City was approved at the time by the Premier League and the FA's compliance unit, " it said.